| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Reynold A Panettieri | Q96255784 |
| P2093 | author name string | Gautam Damera | |
| P2860 | cites work | Cooperative mitogenic signaling by G protein-coupled receptors and growth factors is dependent on G(q/11) | Q83839356 |
| Expression of the dystrophin-glycoprotein complex is a marker for human airway smooth muscle phenotype maturation | Q24300051 | ||
| Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction | Q24647748 | ||
| Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13 | Q24653680 | ||
| Autocrine regulation of asthmatic airway inflammation: role of airway smooth muscle | Q24798934 | ||
| Cigarette smoke induces IL-8, but inhibits eotaxin and RANTES release from airway smooth muscle | Q24814252 | ||
| Induction and regulation of matrix metalloproteinase-12 in human airway smooth muscle cells | Q25255875 | ||
| Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes | Q28139479 | ||
| CysLT1 receptor upregulation by TGF-β and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4 | Q28203816 | ||
| Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines | Q28253247 | ||
| Cysteinyl leukotrienes and their receptors: molecular and functional characteristics | Q28283980 | ||
| Prostanoids as pharmacological targets in COPD and asthma | Q28295555 | ||
| Autocrine interaction between IL-5 and IL-1beta mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle | Q28343578 | ||
| Cellular regulation of RGS proteins: modulators and integrators of G protein signaling | Q28646133 | ||
| Role of human airway smooth muscle in altered extracellular matrix production in asthma | Q32115599 | ||
| Dual modulation of airway smooth muscle contraction by Th2 cytokines via matrix metalloproteinase-1 production | Q33322652 | ||
| Proinflammatory and Th2 cytokines regulate the high affinity IgE receptor (FcepsilonRI) and IgE-dependant activation of human airway smooth muscle cells | Q33479133 | ||
| Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells | Q33508406 | ||
| A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model | Q43846995 | ||
| IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle | Q43882359 | ||
| Upregulation of nerve growth factor expression by human airway smooth muscle cells in inflammatory conditions | Q44126131 | ||
| Interleukin-9 influences chemokine release in airway smooth muscle: role of ERK. | Q44316867 | ||
| Severe asthma in adults: what are the important questions? | Q44683157 | ||
| Signaling pathways regulating interleukin-13-stimulated chemokine release from airway smooth muscle | Q44689962 | ||
| Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways | Q44817455 | ||
| Role of endothelin-1 in regulating proliferation of cultured rabbit airway smooth muscle cells | Q45014953 | ||
| Thymic stromal lymphopoietin receptor-mediated IL-6 and CC/CXC chemokines expression in human airway smooth muscle cells: role of MAPKs (ERK1/2, p38, and JNK) and STAT3 pathways | Q45065700 | ||
| Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta | Q45234446 | ||
| Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus | Q45753588 | ||
| TLR3 activation stimulates cytokine secretion without altering agonist-induced human small airway contraction or relaxation. | Q45960709 | ||
| Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells. | Q45971215 | ||
| Regulation of endothelin-1-induced interleukin-6 production by Ca2+ influx in human airway smooth muscle cells | Q46146098 | ||
| Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. | Q46418233 | ||
| Mechanisms of interleukin 1beta-induced human airway smooth muscle hyporesponsiveness to histamine. Involvement of p38 MAPK NF-kappaB. | Q43562581 | ||
| Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma | Q43601724 | ||
| Serotonin-induced deoxyribonucleic acid synthesis in vascular smooth muscle cells involves a novel, pertussis toxin-sensitive pathway | Q43828580 | ||
| IL-9 induces CCL11 expression via STAT3 signalling in human airway smooth muscle cells | Q33532650 | ||
| Antigen-specific CD4+ T cells drive airway smooth muscle remodeling in experimental asthma | Q33771393 | ||
| Airway wall expression of OX40/OX40L and interleukin-4 in asthma | Q33776845 | ||
| Airway smooth muscle cells: contributing to and regulating airway mucosal inflammation? | Q33942918 | ||
| Non-canonical functions of RGS proteins | Q33945560 | ||
| Eicosanoids in asthma, allergic inflammation, and host defense | Q34013282 | ||
| Expression of IL-4 receptor alpha on smooth muscle cells is not necessary for development of experimental allergic asthma. | Q34050010 | ||
| Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice | Q34177503 | ||
| Pro-inflammatory mechanisms of muscarinic receptor stimulation in airway smooth muscle | Q34203142 | ||
| Distribution and degranulation of airway mast cells in normal and asthmatic subjects | Q34523433 | ||
| Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study | Q34590675 | ||
| Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection | Q34946545 | ||
| Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats | Q35029119 | ||
| Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma | Q35103551 | ||
| Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma | Q35535357 | ||
| Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma | Q35537338 | ||
| Regulation of airway smooth muscle cell immunomodulatory function: role in asthma | Q35546526 | ||
| Human eosinophil-airway smooth muscle cell interactions | Q35609658 | ||
| Ozone modulates IL-6 secretion in human airway epithelial and smooth muscle cells | Q35776527 | ||
| Endothelin-1-induced potentiation of human airway smooth muscle proliferation: an ETA receptor-mediated phenomenon | Q35873519 | ||
| TNF-alpha as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis | Q36201623 | ||
| Airway smooth muscle: a modulator of airway remodeling in asthma | Q36256199 | ||
| T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis | Q36363699 | ||
| Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases | Q36400467 | ||
| Severe asthma: an overview | Q36415900 | ||
| Airway smooth muscle phenotype and function: interactions with current asthma therapies | Q36486084 | ||
| Differential regulation of CCL-11/eotaxin-1 and CXCL-8/IL-8 by gram-positive and gram-negative bacteria in human airway smooth muscle cells | Q36572614 | ||
| Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study | Q36732429 | ||
| Reducing the toll of inflammatory lung disease. | Q36818046 | ||
| Modulating leukocyte recruitment in inflammation | Q36845427 | ||
| The contribution of toll-like receptors to the pathogenesis of asthma | Q36902820 | ||
| The cytokine network in asthma and chronic obstructive pulmonary disease | Q36955575 | ||
| Targeting TNF-alpha: a novel therapeutic approach for asthma | Q37013367 | ||
| Airway smooth muscle in asthma | Q37014839 | ||
| Phenotype and functional plasticity of airway smooth muscle: role of caveolae and caveolins | Q37038070 | ||
| Is airway smooth muscle the "missing link" modulating airway inflammation in asthma? | Q37054746 | ||
| The effects of interleukin-8 on airway smooth muscle contraction in cystic fibrosis | Q37078405 | ||
| Glucocorticoid- and protein kinase A-dependent transcriptome regulation in airway smooth muscle | Q37241622 | ||
| Noncontractile functions of airway smooth muscle cells in asthma | Q37292659 | ||
| Transcriptional regulation of cytokine function in airway smooth muscle cells. | Q37329286 | ||
| Airway smooth muscle as an immunomodulatory cell | Q37329366 | ||
| Airway smooth muscle in asthma: phenotype plasticity and function | Q37359664 | ||
| Lipid metabolites as regulators of airway smooth muscle function | Q37359668 | ||
| Tissue and matrix influences on airway smooth muscle function | Q37365836 | ||
| RGS16 inhibits breast cancer cell growth by mitigating phosphatidylinositol 3-kinase signaling | Q37372117 | ||
| Cysteinyl-leukotrienes in asthmatic airway smooth muscle cell hyperplasia | Q37389173 | ||
| The role of leukotrienes in airway remodeling | Q37438234 | ||
| Role of matrix metalloproteinases in the inflammatory process of respiratory diseases | Q37612266 | ||
| The role of toll-like receptors in chronic inflammation | Q37616733 | ||
| TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath water | Q37620762 | ||
| An update on the role of leukotrienes in asthma | Q37633331 | ||
| Fine-tuning of GPCR activity by receptor-interacting proteins | Q37638132 | ||
| Airway structural components drive airway smooth muscle remodeling in asthma | Q37653476 | ||
| Human airway smooth muscle cells from asthmatic individuals have CXCL8 hypersecretion due to increased NF-kappa B p65, C/EBP beta, and RNA polymerase II binding to the CXCL8 promoter | Q37711402 | ||
| PDGF-induced human airway smooth muscle cell proliferation requires STAT3 and the small GTPase Rac1. | Q38293095 | ||
| PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells | Q39793680 | ||
| Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells | Q39815072 | ||
| Mast cell-dependent contraction of human airway smooth muscle cell-containing collagen gels: influence of cytokines, matrix metalloproteases, and serine proteases | Q39826469 | ||
| Matrix metalloproteinase expression and activity in human airway smooth muscle cells. | Q40533202 | ||
| Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines | Q41088490 | ||
| Allergic and nonallergic interactions between house dust mite allergens and airway mucosa | Q41386768 | ||
| Beta-tryptase regulates IL-8 expression in airway smooth muscle cells by a PAR-2-independent mechanism | Q41843051 | ||
| Human airway smooth muscle promotes eosinophil differentiation | Q42170514 | ||
| Effect of IL-1 beta on responses of cultured human airway smooth muscle cells to bronchodilator agonists | Q42439858 | ||
| Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells | Q42454111 | ||
| Bradykinin stimulates IL-8 production in cultured human airway smooth muscle cells: role of cyclooxygenase products. | Q42460658 | ||
| Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors | Q42541810 | ||
| And the winner is ... RGS4! | Q42545079 | ||
| Airway epithelium stimulates smooth muscle proliferation | Q42553520 | ||
| Aclidinium bromide abrogates allergen-induced hyperresponsiveness and reduces eosinophilia in murine model of airway inflammation. | Q42877129 | ||
| A regulatory role for cAMP in phosphatidylinositol 3-kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-growth-factor-stimulated bovine airway smooth-muscle cells | Q42983831 | ||
| Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD. | Q43110700 | ||
| TNFalpha-induced GM-CSF release from human airway smooth muscle cells depends on activation of an ET-1 autoregulatory positive feedback mechanism | Q43256380 | ||
| Matrix metalloproteinase-19 deficiency promotes tenascin-C accumulation and allergen-induced airway inflammation | Q43258110 | ||
| Bi-directional activation between human airway smooth muscle cells and T lymphocytes: role in induction of altered airway responsiveness | Q43512768 | ||
| Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. | Q46513005 | ||
| Cyclic mechanical strain-induced proliferation and migration of human airway smooth muscle cells: role of EMMPRIN and MMPs | Q46598796 | ||
| The effects of leptin on airway smooth muscle responses | Q46638062 | ||
| Thromboxane A2 induces airway constriction through an M3 muscarinic acetylcholine receptor-dependent mechanism | Q46769476 | ||
| Cooperative regulation of p70S6 kinase by receptor tyrosine kinases and G protein-coupled receptors augments airway smooth muscle growth | Q46785132 | ||
| Human lung mast cells adhere to human airway smooth muscle, in part, via tumor suppressor in lung cancer-1. | Q46880126 | ||
| Complete inhibition of allergic airway inflammation and remodelling in quadruple IL-4/5/9/13-/- mice. | Q46990384 | ||
| Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta | Q47594174 | ||
| Agonists of toll-like receptors 2 and 4 activate airway smooth muscle via mononuclear leukocytes | Q47863174 | ||
| IL-17A augments TNF-alpha-induced IL-6 expression in airway smooth muscle by enhancing mRNA stability | Q47913203 | ||
| The integrin very late antigen-4 is expressed in human smooth muscle cell. Involvement of alpha 4 and vascular cell adhesion molecule-1 during smooth muscle cell differentiation | Q48054724 | ||
| Elevated levels of the IGF-binding protein protease MMP-1 in asthmatic airway smooth muscle | Q50336343 | ||
| Airway structural alterations selectively associated with severe asthma. | Q51690348 | ||
| Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. | Q51720484 | ||
| Der p2 activates airway smooth muscle cells in a TLR2/MyD88-dependent manner to induce an inflammatory response. | Q51748420 | ||
| Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure. | Q52059846 | ||
| Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle. | Q52541175 | ||
| Extracellular matrix proteins differentially regulate airway smooth muscle phenotype and function. | Q53571819 | ||
| Collagen I and thrombin activate MMP-2 by MMP-14-dependent and -independent pathways: implications for airway smooth muscle migration. | Q53581051 | ||
| alpha-Thrombin increases cytosolic calcium and induces human airway smooth muscle cell proliferation. | Q54166692 | ||
| Interleukin-1beta up-regulates tumor necrosis factor receptors in the mouse airways. | Q54530681 | ||
| Effects of interleukin-1beta, interleukin-13 and transforming growth factor-beta on gene expression in human airway smooth muscle using gene microarrays. | Q54703891 | ||
| Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration | Q58421324 | ||
| Two growth factor signalling pathways in fibroblasts distinguished by pertussis toxin | Q59054225 | ||
| Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle | Q59177740 | ||
| Oncostatin M causes eotaxin-1 release from airway smooth muscle: Synergy with IL-4 and IL-13 | Q60609577 | ||
| Histamine and tryptase modulate asthmatic airway smooth muscle GM-CSF and RANTES release | Q61876999 | ||
| Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma | Q61951625 | ||
| Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptor gamma in a murine model of toluene diisocyanate-induced asthma | Q64377482 | ||
| Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells | Q70405076 | ||
| Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma | Q70906164 | ||
| Leukotriene D4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells | Q71978200 | ||
| IFN-gamma inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway | Q73006510 | ||
| Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines | Q73031885 | ||
| Bronchoalveolar lavage fluid from asthmatic subjects is mitogenic for human airway smooth muscle | Q73251139 | ||
| Effects of growth factors and extracellular matrix on survival of human airway smooth muscle cells | Q77190713 | ||
| Rhinovirus elicits proasthmatic changes in airway responsiveness independently of viral infection | Q77347946 | ||
| Endothelin-stimulated ERK activation in airway smooth-muscle cells requires calcium influx and Raf activation | Q77742507 | ||
| Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation | Q77747398 | ||
| Platelet-derived growth factor stimulation of mitogen-activated protein kinases and cyclin D1 promoter activity in cultured airway smooth-muscle cells. Role of Ras | Q77788888 | ||
| Regulation of gelatinases in human airway smooth muscle cells: mechanism of progelatinase A activation | Q78009358 | ||
| Leukotriene D4-induced, epithelial cell-derived transforming growth factor beta1 in human bronchial smooth muscle cell proliferation | Q79920857 | ||
| Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease | Q80019628 | ||
| Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle | Q80175364 | ||
| Role and regulation of interleukin-1 molecules in pro-asthmatic sensitised airway smooth muscle | Q80809696 | ||
| Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation | Q82879026 | ||
| Regulation of Toll-like receptor 4-induced proasthmatic changes in airway smooth muscle function by opposing actions of ERK1/2 and p38 MAPK signaling | Q83042497 | ||
| GRO-alpha regulation in airway smooth muscle by IL-1beta and TNF-alpha: role of NF-kappaB and MAP kinases | Q83159040 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| phenotype | Q104053 | ||
| asthma | Q35869 | ||
| P304 | page(s) | 68-80 | |
| P577 | publication date | 2011-05-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Does airway smooth muscle express an inflammatory phenotype in asthma? | |
| P478 | volume | 163 |
| Q55214049 | A candidate gene identification strategy utilizing mouse to human big-data mining: "3R-tenet" in COPD genetic research. |
| Q38240756 | A-kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases |
| Q37891134 | Airway smooth muscle and immunomodulation in acute exacerbations of airway disease |
| Q38233318 | Asthma therapy and its effect on airway remodelling. |
| Q28087345 | CD38 and airway hyper-responsiveness: studies on human airway smooth muscle cells and mouse models |
| Q39035203 | CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets |
| Q99237827 | Contributions of IL-33 in Non-hematopoietic Lung Cells to Obstructive Lung Disease |
| Q37704454 | Dietary patterns and the risk of rhinitis in primary school children: a prospective cohort study. |
| Q92002839 | FGF2, an Immunomodulatory Factor in Asthma and Chronic Obstructive Pulmonary Disease (COPD) |
| Q90216474 | Hyperoxia-induced Cellular Senescence in Fetal Airway Smooth Muscle Cells |
| Q26751439 | Inhaled protein/peptide-based therapies for respiratory disease |
| Q54339682 | Last Word on Point: Alterations in airway smooth muscle phenotype do cause airway hyperresponsiveness in asthma. |
| Q35964610 | MicroRNA Mediated Chemokine Responses in Human Airway Smooth Muscle Cells |
| Q92130987 | Smooth-muscle-derived WNT5A augments allergen-induced airway remodelling and Th2 type inflammation |
| Q42725432 | Special issue of BJP on respiratory pharmacology. |
| Q26776067 | Statins in Asthma: Potential Beneficial Effects and Limitations |
| Q54536233 | TLR2 ligand engagement upregulates airway smooth muscle TNFα-induced cytokine production. |
| Q36480356 | TLR3 activation increases chemokine expression in human fetal airway smooth muscle cells. |
| Q37955927 | Targeting airway smooth muscle in airways diseases: an old concept with new twists |
| Q42265456 | The nucleotide-binding domain and leucine-rich repeat protein-3 inflammasome is not activated in airway smooth muscle upon toll-like receptor-2 ligation. |
| Q36499489 | The parasitic worm-derived immunomodulator, ES-62 and its drug-like small molecule analogues exhibit therapeutic potential in a model of chronic asthma |
| Q38944559 | Total synthesis and biological evaluation of the natural product (-)-cyclonerodiol, a new inhibitor of IL-4 signaling |
Search more.